p110δ结构：新型磷脂酰肌醇-3-激酶（PI(3)K）抑制剂的选择性和效力机制 - Suppr | 超能文献

The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.

作者信息

Berndt Alex, Miller Simon, Williams Olusegun, Le Daniel D, Houseman Benjamin T, Pacold Joseph I, Gorrec Fabrice, Hon Wai-Ching, Liu Yi, Rommel Christian, Gaillard Pascale, Rückle Thomas, Schwarz Matthias K, Shokat Kevan M, Shaw Jeffrey P, Williams Roger L

出版信息

Nat Chem Biol. 2010 Mar;6(3):244. doi: 10.1038/nchembio0310-244b.

DOI:10.1038/nchembio0310-244b

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.p110δ结构：新型磷脂酰肌醇-3-激酶（PI(3)K）抑制剂的选择性和效力机制

Nat Chem Biol. 2010 Mar;6(3):244. doi: 10.1038/nchembio0310-244b.

2

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.PI(3)K p110δ 的失活破坏了调节性 T 细胞介导的对癌症的免疫耐受。

Nature. 2014 Jun 19;510(7505):407-411. doi: 10.1038/nature13444. Epub 2014 Jun 11.

3

The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.p110δ 结构：新型 PI(3)K 抑制剂的选择性和效力机制。

Nat Chem Biol. 2010 Feb;6(2):117-24. doi: 10.1038/nchembio.293.

4

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ.针对 PI3K 同工型 p110δ 的药物的功能影响和分子结合模式。

Commun Biol. 2023 Jun 5;6(1):603. doi: 10.1038/s42003-023-04921-z.

5

Role of the p110delta PI 3-kinase in integrin and ITAM receptor signalling in platelets.p110δ磷脂酰肌醇3-激酶在血小板整合素和免疫受体酪氨酸激活基序（ITAM）受体信号传导中的作用

Platelets. 2005 May-Jun;16(3-4):191-202. doi: 10.1080/09537100400016711.

6

Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase.p110δ磷脂酰肌醇-3激酶对感觉神经元轴突生长和再生的调控

PLoS One. 2007 Sep 11;2(9):e869. doi: 10.1371/journal.pone.0000869.

7

Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury.抑制 p110δ PI3K 可预防动脉损伤后的炎症反应和再狭窄。

Biosci Rep. 2017 Sep 27;37(5). doi: 10.1042/BSR20171112. Print 2017 Oct 31.

8

Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.p110δ磷酸肌醇3激酶的基因阻断或药物阻断可增强IgE的产生。

J Allergy Clin Immunol. 2008 Oct;122(4):811-819.e2. doi: 10.1016/j.jaci.2008.08.008.

9

The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.PI(3)K 的 p110δ 同工型控制 TLR4 信号的亚细胞区室化，并防止内毒素休克。

Nat Immunol. 2012 Nov;13(11):1045-1054. doi: 10.1038/ni.2426. Epub 2012 Sep 30.

10

Regulation of p110delta PI 3-kinase gene expression.p110δ磷脂酰肌醇-3激酶基因表达的调控

PLoS One. 2009;4(4):e5145. doi: 10.1371/journal.pone.0005145. Epub 2009 Apr 9.

引用本文的文献

1

Interim analysis: Open-label extension study of leniolisib for patients with APDS.临时分析：APDS 患者用 leniolisib 的开放标签扩展研究。

J Allergy Clin Immunol. 2024 Jan;153(1):265-274.e9. doi: 10.1016/j.jaci.2023.09.032. Epub 2023 Oct 4.

2

Class I PI3K Biology.I 类 PI3K 生物学。

Curr Top Microbiol Immunol. 2022;436:3-49. doi: 10.1007/978-3-031-06566-8_1.

3

Design, Synthesis, and Development of pyrazolo[1,5-]pyrimidine Derivatives as a Novel Series of Selective PI3K Inhibitors: Part I-Indole Derivatives.新型选择性PI3K抑制剂吡唑并[1,5 - ]嘧啶衍生物的设计、合成与开发：第一部分 - 吲哚衍生物

Pharmaceuticals (Basel). 2022 Jul 30;15(8):949. doi: 10.3390/ph15080949.

4

Design, Synthesis, and Development of Pyrazolo[1,5-]pyrimidine Derivatives as a Novel Series of Selective PI3K Inhibitors: Part II-Benzimidazole Derivatives.吡唑并[1,5 - ]嘧啶衍生物作为新型系列选择性PI3K抑制剂的设计、合成与开发：第二部分 - 苯并咪唑衍生物

Pharmaceuticals (Basel). 2022 Jul 27;15(8):927. doi: 10.3390/ph15080927.

5

PI3K inhibitors are finally coming of age.PI3K 抑制剂终于迎来了黄金时代。

Nat Rev Drug Discov. 2021 Oct;20(10):741-769. doi: 10.1038/s41573-021-00209-1. Epub 2021 Jun 14.

6

Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors.多功能氧化吲哚作为选择性PI3Kδ抑制剂的优化

ACS Med Chem Lett. 2020 Nov 19;11(12):2461-2469. doi: 10.1021/acsmedchemlett.0c00441. eCollection 2020 Dec 10.

7

For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors.好或坏：限制 PI3K 抑制剂的靶毒性的潜在可能性。

Biomolecules. 2019 Aug 22;9(9):402. doi: 10.3390/biom9090402.

8

Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.隐蔽口袋形成是毒蕈碱型乙酰胆碱受体变构调节剂选择性的基础。

Nat Commun. 2019 Jul 23;10(1):3289. doi: 10.1038/s41467-019-11062-7.

9

Aberrant RNA Splicing in Cancer and Drug Resistance.癌症与耐药性中的异常RNA剪接

Cancers (Basel). 2018 Nov 20;10(11):458. doi: 10.3390/cancers10110458.

10

Structure-Guided Design and Initial Studies of a Bifunctional MEK/PI3K Inhibitor (ST-168).双功能MEK/PI3K抑制剂（ST-168）的结构导向设计及初步研究

ACS Med Chem Lett. 2017 Jul 24;8(8):808-813. doi: 10.1021/acsmedchemlett.7b00111. eCollection 2017 Aug 10.

本文引用的文献

1

The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.p110δ 结构：新型 PI(3)K 抑制剂的选择性和效力机制。

Nat Chem Biol. 2010 Feb;6(2):117-24. doi: 10.1038/nchembio.293.